Key market metrics for Fortis Healthcare (India) Ltd. (FORTIS) listed on NSE. For healthcare sector companies, these metrics provide a snapshot of Fortis Healthcare (India) Ltd.'s market valuation and enterprise value, essential for comparing against intrinsic value estimates.
We analyze Fortis Healthcare (India) Ltd. using multiple valuation models appropriate for HEALTHCARE companies. For HEALTHCARE companies, we use P/E Ratio Analysis, Discounted Cash Flow (DCF), and EPS Growth Valuation to determine fair value estimates for Fortis Healthcare (India) Ltd. stock.
10-year Price-to-Earnings ratio trend
Current P/E Ratio
90.67
Jun 03, 2026
5-Year Median P/E
58.66
5-Year Historical Median
Difference
32.01
54.6%
Analysis: Fortis Healthcare (India) Ltd.'s current P/E ratio is 54.6% above its 5-year median, suggesting the stock may be overvalued relative to its historical earnings performance.
The P/E ratio measures how much investors pay for each rupee of earnings (Share Price / EPS). A higher PE suggests the market expects strong future growth, while a lower PE may indicate undervaluation or slower growth prospects. Compare Fortis Healthcare (India) Ltd.'s current PE against its historical median and HEALTHCARE peers to gauge whether the stock is trading at a premium or discount relative to its earnings.
Go beyond charts — get fair value estimates from multiple valuation models and detailed assessment breakdowns.
Just ₹833/month
Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: FY 2025